U-Chart Analysis:Cyfuse Biomedical K.K.:4892

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Cyfuse Biomedical K.K. 4892 Medicals 東証グロース December 1, 2000 2022.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Cyfuse Biomedical K.K. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Balance Sheet 2024年12月期 Cyfuse Biomedical K.K. Balance Sheet 2023年12月期 Cyfuse Biomedical K.K. Balance Sheet 2022年12月期 Cyfuse Biomedical K.K. Balance Sheet 2021年12月期 Cyfuse Biomedical K.K. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 3,053 3,874 4,437 2,413 2,073
Other Current AssetsHelp 188 114 128 146 79
Tangible Fixed AssetsHelp 142 170 189 27 33
Intangible Fixed AssetHelp 4 4 5 5 6
Investments and OthersHelp 132 53 55 56 6
Total AssetsHelp 3,518 4,215 4,815 2,646 2,196
Total Current LiabilitiesHelp 649 666 683 386 207
Total Long-term LiabilitiesHelp 327 345 363 360 440
Shareholder's EquityHelp 2,542 3,203 3,770 1,900 1,549
Total LiabilitiesHelp 3,518 4,215 4,815 2,646 2,196

Cyfuse Biomedical K.K. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Profit and Loss Account 2024年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2023年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2022年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2021年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 54 61 374 708 137
Total Sales 54 61 374 708 137
Cost of SalesHelp 38 23 133 138 70
Other Costs and RevenueHelp 889 627 715 428 397
Total CostsHelp 927 650 848 565 467
Net RevenueHelp 17 38 241 571 67
Earnings Before TaxHelp -870 -586 -472 145 -327
Net IncomeHelp -872 -589 -474 143 -330
Net Income -872 -589 -474 143 -330

Cyfuse Biomedical K.K. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Cash Flow Statement 2024年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2023年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2022年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2021年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help -761 -562 -404 162 -294
Investing Cash Flow(ICF)Help -9 -19 -431 -51 -0
Financing Cash FlowHelp -52 18 2,659 229 489
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -821 -564 1,824 340 195

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Cyfuse Biomedical K.K.
KAWADEN CORPORATION
Soiken Holdings Inc.
TOYO DENKI SEIZO K.K.
SEIKOH GIKEN Co.,Ltd.

Company where related level is highHelp

Perseus Proteomics Inc.
Astellas Pharma Inc.
StemRIM Inc.
NANO MRNA Co., Ltd.
Otsuka Holdings Co.,Ltd.
Fuji Pharma Co.,Ltd.
TSUMURA & CO.
TAISHO PHARMACEUTICAL CO.,LTD.
Kidswell Bio Corporation
MEDICAL & BIOLOGICAL LABORATORIES CO.